Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects.
D000200:Action Potentials; D001949:Bretylium Compounds / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D004562:Electrocardiography; D005080:Exercise Test; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013610:Tachycardia / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D014693:Ventricular Fibrillation / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy
D001949:Bretylium Compounds; D004071:Digitalis Glycosides; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011342:Procainamide